Activity of the new cephalosporin CXA-101 (FR264205) against Pseudomonas aeruginosa isolates from chronically-infected cystic fibrosis patients

By Zamorano L.   Juan C.   Fernández-Olmos A.   Ge Y.   Cantón R.   Oliver A.  

Clinical Microbiology & Infection, Vol. 16, Iss. 9, 2010-09 ,pp. : 1482-1487

Blackwell Publishing

Access to resources Recommend Favorite

Clinical impact of a highly prevalent Pseudomonas aeruginosa clone in Dutch cystic fibrosis patients

By de Vrankrijker A. M. M.   Brimicombe R. W.   Wolfs T. F. W.   Heijerman H. G. M.   van Mansfeld R.   van Berkhout F. T.   Willems R. J. L.   Bonten M. J. M.   van der Ent C. K.  

Clinical Microbiology & Infection, Vol. 17, Iss. 3, 2011-03 ,pp. : 382-385

Blackwell Publishing

Access to resources Recommend Favorite

Factors associated with mucoid transition of Pseudomonas aeruginosa in cystic fibrosis patients

By Martha B.   Croisier D.   Fanton A.   Astruc K.   Piroth L.   Huet F.   Chavanet P.  

Clinical Microbiology & Infection, Vol. 16, Iss. 6, 2010-06 ,pp. : 617-623

Blackwell Publishing

Access to resources Recommend Favorite

Stationary biofilm growth normalizes mutation frequencies and mutant prevention concentrations in Pseudomonas aeruginosa from cystic fibrosis patients

By García-Castillo M.   del Campo R.   Baquero F.   Morosini M.-I.   Turrientes M.-C.   Zamora J.   Cantón R.  

Clinical Microbiology & Infection, Vol. 17, Iss. 5, 2011-05 ,pp. : 704-711

Blackwell Publishing

Access to resources Recommend Favorite

Type 3 secretion system effector genotype and secretion phenotype of longitudinally collected Pseudomonas aeruginosa isolates from young children diagnosed with cystic fibrosis following newborn screening

By Hu H.   Harmer C.   Anuj S.   Wainwright C. E.   Manos J.   Cheney J.   Harbour C.   Zablotska I.   Turnbull L.   Whitchurch C. B.   Grimwood K.   Rose B.    

Clinical Microbiology & Infection, Vol. 19, Iss. 3, 2013-03 ,pp. : 266-272

Blackwell Publishing

Access to resources Recommend Favorite